Edwards Lifesciences (EW) EBITDA (2009 - 2026)
Edwards Lifesciences (EW) EBITDA from Jun 30, 2009 to Mar 31, 2026. The TTM Edwards Lifesciences (EW) EBITDA is $1.51B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Edwards Lifesciences (EW) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -4.43% |
| 3 Years TTM | -1.71% |
| 5 Years TTM | +7.75% |
| 10 Years TTM | +7.55% |
| All Time TTM | +12.37% |
Annual EBITDA change of Edwards Lifesciences (EW)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $519M | -63.51% |
| 2025 | $1.42B | -7.37% |
| 2024 | $1.53B | +5.51% |
| 2023 | $1.45B | -11.25% |
| 2022 | $1.64B | -10.25% |
| 2021 | $1.83B | +81.64% |
| 2020 | $1B | -18.71% |
| 2019 | $1.24B | +49.72% |
| 2018 | $826M | -29.51% |
| 2017 | $1.17B | +42.42% |
| 2016 | $822M | +16.59% |
| 2015 | $705M | -42.64% |
| 2014 | $1.23B | +110.62% |
| 2013 | $584M | +30.83% |
| 2012 | $446M | +29.47% |
| 2011 | $345M | +5.38% |
| 2010 | $327M | -10.58% |
| 2009 | $366M | +61.00% |
| 2008 | $227M | N/A |
Comparison Edwards Lifesciences (EW) five years EBITDA CAGR with competitors
Edwards Lifesciences (EW) five years EBITDA CAGR is 7.75%.